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Abstracts 
Purpose: Blood loss and blood substitution are associated with higher morbidity after 
major abdominal surgery. During major liver resection, low local venous pressure, 
has been shown to reduce blood loss. Ambiguity persists concerning the impact of 
local venous pressure on blood loss during open radical cystectomy. We aimed to 
determine the association between intraoperative blood loss and pelvic venous 
pressure (PVP) and determine factors affecting PVP. 
Material and Methods: In the frame of a single-center, double-blind, randomized 
trial, PVP was measured in 82 patients from a norepinephrine/low-volume group and 
in 81 from a control group with liberal hydration. For this secondary analysis, patients 
from each arm were stratified into subgroups with PVP <5 mmHg or ≥5 mmHg 
measured after cystectomy (optimal cut-off value for discrimination of patients with 
relevant blood loss according to the Youden’s index). 
Results: Median blood loss was 800 ml [range: 300-1600] in 55/163 patients (34%) 
with PVP <5 mmHg and 1200 ml [400-3000] in 108/163 patients (66%) with PVP ≥5 
mmHg; (P<0.0001). A PVP <5 mmHg was measured in 42/82 patients (51%) in the 
norepinephrine/low-volume group and 13/81 (16%) in the control group (P<0.0001). 
PVP dropped significantly after removal of abdominal packing and abdominal lifting in 
both groups at all time points (at begin and end of pelvic lymph node dissection, end 
of cystectomy) (P<0.0001). No correlation between PVP and central venous pressure 
could be detected. 
Conclusions: Blood loss was significantly reduced in patients with low PVP. Factors 
affecting PVP were fluid management and abdominal packing. 
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Introduction: 
During open radical cystectomy (RC) combined with pelvic lymph node dissection 
(PLND) and urinary diversion (UD), bleeding from the local pelvic venous plexus and 
capillaries surrounding the bladder and prostate may be substantial despite 
meticulous surgery. Strategies to reduce blood loss need to be developed aiming to 
reduce the incidence of blood transfusion and improve postoperative outcome. In the 
frame of a prospective randomized trial, we recently showed that an intraoperative 
preemptive norepinephrine administration combined with a restrictive deferred 
hydration significantly reduces postoperative complications, blood loss and the need 
for blood transfusion1,2. Whether this is due to a decreased local venous pressure or 
other factors (vasoconstriction or minimal change in the concentration of coagulation 
factors) is not known. Local venous pressure in the surgical field may influence blood 
loss. Low (<5 mmHg) central venous pressure (CVP) is considered a simple and 
potent method to minimize intraoperative blood loss during liver resection surgery 3-5. 
Therefore, we investigated whether blood loss also correlates with pelvic venous 
pressure (PVP), a surrogate for the local venous pressure around the bladder and 
prostate, during open RC combined with PLND and UD under two different 
intraoperative fluid management strategies: a preemptive norepinephrine infusion 
combined with a restrictive deferred hydration or a more liberal hydration without 
norepinephrine. In addition, the impact of abdominal packing on PVP was analysed. 
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Methods 
Trial design and participants 
This randomized double-blind single-centre study was approved by the local ethics 
committee (KEK Bern) and registered at Clinicaltrials.gov (NCT01276665). Patients 
with an ASA score of II to III were included. Exclusion criteria were coagulopathies, 
significant hepatic and renal dysfunction (Kidney Disease Outcomes Quality Initiative 
stage ≥3), congestive heart failure and contraindication for thoracic epidural 
analgesia. All patients provided written informed consent. Between November 2009 
and September 2012, 167 consecutive patients scheduled for PLND, open RC and 
UD. Patients were prospectively randomized into two groups: a preemptive 
administration of norepinephrine combined with a restrictive deferred crystalloid fluid 
regimen (norepinephrine/low-volume group) or a more liberal i.v. hydration (control 
group). 
For this analysis, only patients with available data on intraoperative PVP 
measurements were evaluated (Figure 1). 
Initial randomization and blinding: 
The protocol and design of the original study has been described previously 1. Briefly, 
patients were randomly allocated to the norepinephrine/low-volume group or to the 
control group by using a computer generated permuted block randomization with 1:1 
allocation. 
Surgeons, patients and data assessors were blinded to the assigned fluid regimens. 
Crystalloids bags and perfusions pumps were hidden behind a sterile curtain during 
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surgery. Assessors of the postoperative data had no access to the anesthesiologic 
patients’ data. 
Patient management 
Standard monitoring included continuous ECG, heart rate, core temperature, SpO2, 
invasive mean arterial pressure (MAP) and CVP. Before induction of anesthesia, an 
epidural catheter was placed at the T9/T10 level and activated with bupivacaine 
0.25% at a rate of 8 ml/h until the end of the PLND. Anesthesia was induced with 
propofol, fentanyl, rocuronium and maintained with isoflurane. Ventilation with an 
inspired oxygen fraction of 60% was mechanically controlled to maintain 
normocapnia. Normothermia was maintained with an air warming system and fluid 
warmer. 
In the norepinephrine/low-volume group, a preemptive norepinephrine infusion was 
started at 2 µg/kg/h after the induction of anesthesia and 1 ml/kg/h of a balanced 
crystalloid solution (Ringerfundin®, B. Braun Medical AG, Sempach, Switzerland) 
was administrated until the bladder had been removed, followed by 3 ml/kg/h of 
crystalloid until the end of surgery while maintaining the norepinephrine infusion. In 
case of hypotension (i.e. MAP <60 mmHg), the norepinephrine infusion was titrated 
accordingly after an initial bolus of 10 µg. In the control group, a bolus of 6 ml/kg of 
crystalloid was administrated during induction of anesthesia, followed by 6 ml/kg/h of 
balanced crystalloid solution intraoperatively. In this group, episodes of hypotension 
were treated with boluses of 250 ml of crystalloid solution. In all patients, blood units 
were only transfused when the hemoglobin was <8.0 gr/dl 6. 
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Patients were in 30° head-down position during the whole duration of surgery. The 
surgical technique was standardized 7,8. At least one of 3 senior urologists (FCB, 
GNT, UES) was present during surgery. 
Data collection and outcome measures 
Blood loss was assessed by the anaesthesiologists based on the amount of blood 
in the suction device and the blood volume absorbed in the surgical gauzes 
(weighed). Blood loss was assessed separately during the PLND, open RC and UD 
periods 2. The number of patients who received blood unit transfusions during 
surgery was documented. 
During surgery, heart rate, invasive MAP, and CVP were continuously registered and 
their mean values calculated. Assessment of the pelvic venous pressure (PVP) was 
done 4 times invasively with a 20G needle placed in the external iliac vein adjacent to 
the iliac bifurcation. The pressure transducers were calibrated and zeroed separately 
and levelled to the external iliac vein. PVP measurements were recorded after 
preparation of the iliac bifurcation (i.e. begin of the PLND), at the end of the pelvic 
lymph node dissection, after removal of the bladder (i.e. end of the cystectomy part), 
and finally before closure of the abdominal wall (i.e. end of the UD part). At these 
defined time points (except before closure of the abdominal wall), PVP was 
measured first with the gauzes placed in the abdominal cavity (in order to remove the 
bowel from the surgical field, i.e. abdominal packing) and a second time after removal 
of the gauzes with the abdominal wall lifted, in order to analyze the impact of the 
gauzes/packing on venous return. Mean PVP was also calculated. 
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Patients were analyzed in subgroups according to whether their PVP at the end of 
the cystectomy part was associated with a clinically relevant blood loss, (i.e. need for 
blood unit transfusion). 
Statistical analysis 
Data were analyzed using non-parametric statistical models. Data are expressed as 
median values with ranges or numbers (%). Categorical data were compared with the 
chi square test. Relative risks (RR) and 95% CI were also calculated when 
appropriate. Continuous data were compared using the two-tailed Mann-Whitney U 
test and Kruskal-Wallis H test followed by the Bonferroni correction for multiple 
comparisons. Within each group, the within patient’s PVP values with and without 
gauzes were analyzed using the Wilcoxon signed rank tests. Spearman correlation 
tests were used to test the correlation between blood loss and MAP, CVP and PVP at 
the different time points. Test results were considered significant if P <0.05. Receiver 
operating characteristic (ROC) curves were constructed to identify the optimal cut-off 
values for association between blood loss and the need for blood unit transfusion 
(defined as clinically relevant blood loss) and then between mean PVP and clinically 
relevant blood loss. The optimal cut-off was defined as the value associated with the 
highest sum of sensitivity and specificity (Youden’s index). Multiple logistic regression 
analyses using a forward selection procedure were applied to identify independent 
risk factors for relevant blood loss and reported as adjusted odds ratios (ORs) with 
95% CIs. Factors were included if their P values were smaller than 0.10. 
Confounders considered were mean MAP, CVP and PVP. No interaction terms were 
included due to the sample size. The fit and predictive power of the model was 
assessed using the Hosmer–Lemeshow goodness-of-fit test and ROC-area under the 
curve (ROC-AUC). 
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Results 
PVP was assessed in 82 in the norepinephrine/low-volume group and 81 patients in 
the control group (Figure 1). Baseline data were equally distributed between the 
subgroups within the groups (Table 1). 
The ROC-AUC for mean PVP was 0.753 (95% CI 0.659-0.847) according to the 
occurrence of blood loss requiring blood unit transfusions. The optimal cut-off value 
for mean PVP was 5.1 mmHg (84% sensitivity and 64% specificity) for discrimination 
of patients with a relevant blood loss. According to multiple logistic regression 
analysis, PVP (<5 vs ≥5 mmHg) was the only independent predictor for clinically 
relevant blood loss (OR 0.373 [95% CI 0.165-0.842]; P=0.018). MAP (OR 1.054 [95% 
CI 0.984-1.130]; P=0.130) and CVP (OR 1.094 [95% CI 0.974-1.230]; P=0.115) did 
not significantly correlate. The model accorded well with the Hosmer–Lemeshow test 
(P=0.801) and the ROC-AUC was 0.701. 
Independent of the groups, median blood loss was 800 ml [range: 300, 1600] in 
55/163 patients (34%) who had a PVP <5 mmHg and 1200 ml [400, 2800] in 108/163 
patients (66%) with a PVP ≥5 mmHg; (P<0.0001). Independent of the groups, PVP 
were found to be significantly correlated with blood loss at the end of PLND at 
r2=0.234 ([95% CI: 0.096-0.397], P=0.004). At the end of the cystectomy part, CVP 
and PVP significantly correlated with blood loss during this period at r2=0.241 ([95% 
CI: 0.085-0.384], P=0.006) and r2=0.344 ([95% CI: 0.155-0.469], P<0.0001), 
respectively. At the end of the UD period, PVP significantly correlated with blood loss 
during this period at r2=0.190 ([95% CI: 0.022-0.371], P=0.022) (Figure 2). CVP and 
PVP were not significantly correlated, with the exception of a weak correlation which 
was observed at the end of cystectomy r2=0.134 ([95% CI: 0.019-0.259], P=0.025).  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
In the norepinephrine/low-volume group, PVP significantly correlated with blood loss 
at the end of the cystectomy part and at the end of the UD part at r2=0.244 ([95% CI: 
0.021-0.461], P=0.032) and r2=0.269 ([95% CI: 0.024-0.495], P=0.019), respectively. 
In the control group, no significant correlation could detected between PVP values 
and blood loss during the different time periods. 
PVP was significant lower in the norepinephrine/low-volume group during all periods 
assessed compared to the control group (Table 2). A PVP <5 mmHg at the end of the 
cystectomy part was present in 42/82 patients (51%) in the norepinephrine/low-
volume group and in 13/81 patients (16%) in the control group [RR: 0.58 (95% CI: 
0.46-0.74), P<0.0001]. A PVP <5 mmHg at the end of the cystectomy part was 
associated with significantly less intraoperative blood loss in both groups: Median 
total blood loss for the subgroup PVP with a <5 mmHg in the norepinephrine/low-
volume group was 800 ml [300, 1200] vs 900 ml [500, 1800] in the subgroup with a 
PVP ≥5 mmHg; P=0.004. In the control group, the subgroup PVP <5 mmHg had a 
median blood loss of 1000 ml [600, 1600] compared to 1300 ml [400, 3000] in the 
subgroup with a PVP ≥5 mmHg; P=0.006 (Figure 3). 
PVP dropped significantly (P<0.0001) after removal of the gauzes from the 
abdominal cavity and lifting of the abdominal wall in both groups at any measurement 
time point (Table 2). 
There was a significant difference in the rate of blood unit transfusion given between 
the patients with a PVP <5 mmHg and patients with a PVP ≥5 mmHg (5/55 patients 
(9%) vs 28/108 patients (26%); RR: 0.72, 95% CI: 0.10 to 0.79, P=0.013), but no 
difference between the subgroups within each randomized group 
(norepinephrine/low-volume group: subgroup PVP <5 mmHg 3/42 patients (7%) vs 
4/40 patients (10%) in the subgroup PVP ≥5 mmHg; P=0.709 and control group: 
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subgroup PVP <5 mmHg 2/13 patients (15%) vs 24/68 patients (35%) patients in the 
subgroup PVP ≥5 mmHg; P=0.206). 
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Discussion 
Total intraoperative blood loss was significantly lower in patients with a low PVP (<5 
mmHg) compared to patients with a PVP ≥5 mmHg. A significantly larger number of 
patients with a preemptive infusion of norepinephrine combined with a restrictive 
deferred hydration had a PVP <5 mmHg. Even in this group, increased PVP was 
associated with an increased blood loss. This suggests that fluid management can 
influence PVP and consequently impact blood loss.  
Blood loss during open RC with UD has an impact on postoperative outcome and 
increases postoperative morbidity9-12. Blood unit transfusion following excessive 
blood loss carries the risk of transfusion associated lung injury, postoperative 
transfusion associated fluid overload, increased wound infection rates and has been 
postulated to promote cancer recurrence13-15. Consequently, intraoperative strategies 
aiming to reduce blood loss may have vital consequences. 
Little is known about the impact of the venous pressure in the surgical site on blood 
loss. Substantial literature could already demonstrate that a significant reduction in 
blood loss can be achieved by maintaining a CVP lower than 5 mmHg in patients 
undergoing liver dissection and thus making control of vascular injury easier 3,4. In 
this study we could demonstrate that preemptive use of norepinephrine with a 
restrictive deferred fluid management lead to a significant reduction in PVP and blood 
loss when compared with a more liberal fluid regimen. 
The question remains whether the decreased blood loss is attributable to the reduced 
intravenous fluid administration and the vasoconstriction induced by norepinephrine 
resulting in a lower PVP. The correlation between blood loss and PVP independent 
of the amount of fluid administrated emphasizes that PVP significantly impacts blood 
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loss. Even within the control group, in which patients received a more generous fluid 
administration, a PVP <5 mmHg at the end of cystectomy was associated with a 
significant decrease in blood loss. 
An additional important observation was that lifting of the abdominal wall significantly 
reduced PVP. This suggests that avoiding abdominal packing, for example by using a 
table-fixed self-retaining retractor to lift up the abdominal wall, may help reduce 
intraoperative PVP. The potential hemodynamic impact of an abdominal wall-lifting 
retractor compared to conventional abdominal packing in patients undergoing open 
abdominal surgery is less well studied than in laparoscopic surgery. In laparoscopic 
surgery an abdominal wall lifting device has a positive effect on blood loss and CVP 
both in animal models and in patients undergoing cholecystectomy. An abdominal 
wall lifting device resulted in an increased cardiac index compared to carbon dioxide 
insufflation without affecting systemic vascular resistance in healthy patients 
undergoing laparoscopic cholecystectomy and showed less side effects such as 
postoperative nausea and vomiting and right shoulder pain 16,17. For these reasons 
this approach has been recommended for high-risk patients17-20. 
Another important observation was the lack of correlation between PVP and CVP, 
with the exception of a weak correlation at the end of the cystectomy part. Thus, 
standard CVP assessment may not be a reliable surrogate for PVP, a factor which 
has to be taken into account. 
In some of our patients negative PVPs were measured which could potentially be a 
risk for air emboli. However, a Trendelenburg’s position of 30 degrees and packing of 
the pelvis with wet gauzes after removing the bladder should limit the risk of air 
emboli. In addition, no fall in end-tidal carbon dioxide could be detected, thus making 
clinically relevant air emboli unlikely. 
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Limitations: The main limitation is the lack of a specific power analysis concerning the 
reduction in blood loss as this study is a secondary analysis. In addition, PVP 
measurements were only done punctually and not continuously. However, continuous 
monitoring of PVP would imply catheterization of the veins resulting in a higher risk of 
thrombosis. 
Conclusion: 
Our results suggest that low PVP during PLND, RC and UD significantly reduces 
intraoperative blood loss. Techniques to decrease PVP, such as the use of a 
norepinephrine/low-volume regimen and avoidance of compression of the vena cava, 
(e.g. by intraabdominal packing), should be established for open RC and UD. 
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Figure legends:  
Figure 1: Modified Consort flow-chart: 
Figure 2: Correlation between pelvic venous pressure (mmHg) and blood loss (ml) 
during the different time periods including fit lines with 95% confidence intervals; 
sphere size depends on the number of patients (scale). 
Figure 3: Total blood loss according to randomization group and stratified according 
to pelvic venous pressure (PVP); in white norepinephrine/low-volume group and in 
grey the control group: 
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Table 1: Baseline characteristics according to the randomization group and stratified 
according to pelvic venous pressure (PVP) into subgroups “PVP <5mmHg and PVP 
≥5mHg”. Data are presented with median values and ranges: 
  
 
Norepinephrine/low-volume Group       Control Group 
 
 
(n=82) 
  
(n=81) 
 
PVP < 5mmHg PVP ≥ 5mmHg PVP < 5mmHg PVP ≥ 5mmHg 
Number of patients n=42 51% n=40 49% n=13 16% n=68 84% 
     
  
   
Age (yr) 71 [38-86] 67 [40-88] 67 [42-88] 70 [47-88] 
Gender 
    
  
   
Male (n) 28 67% 27 68% 10 77% 48 71% 
Female (n) 14 33% 13 32% 3 23% 20 29% 
BMI (kg.m-2) 23.5 [18-31] 24 [19-42] 25 [21-28] 24 [20-39] 
ASA 
    
  
   
II 23 55% 28 70% 7 54% 39 57% 
III 19 45% 12 30% 6 46% 29 43% 
Biomarkers: 
    
  
   
Brain natriuretic peptide (pg.ml-1) 39.5 [5-350] 22 [5-146] 38 [5-68] 29 [5-341] 
Haemoglobin (g.dl-1) 13 [9.4-15.6] 13 [8.4-15.9] 13.4 [10-16.2] 12.6 [7.3-16.7] 
Thrombocytes (G.l-1) 244 [127-386] 258 [122-576] 250 [173-513] 255 [111-770] 
Prothrombin time (%) 99 [51-100] 100 [66-100] 100 [95-100] 100 [51-100] 
C reactive proteine (mg.l-1) 4 [3-95] 3 [3-197] 3 [3-72] 3 [3-73] 
Albumin (g.l-1) 35 [27-48] 34.5 [19-45] 33 [22-39] 34 [21-49] 
     
  
   
Glasgow prognostic score 
    
  
   
0 19 45% 17 43% 3 23% 25 37% 
1 13 31% 15 38% 7 54% 31 46% 
2 10 24% 8 19% 3 23% 12 17% 
     
  
   
Preoperative use of aspirin 
        
Yes 15 36% 6 15% 1 8% 14 21% 
No 27 64% 34 85% 12 92% 54 79% 
         
Duration of surgery (min) 393 [240-560] 378 [300-540] 390 [210-585] 390 [240-585] 
         
Type of urinary diversion 
        
Ileal conduit 19 45% 13 33% 6 46% 32 47% 
Orthotopic ileal bladder substitute 23 55% 27 67% 7 54% 35 53% 
         
pT stage 
        
pT1-2 23 55% 30 75% 6 46% 42 62% 
pT3-4 19 45% 10 25% 7 54% 26 38% 
         
Neoadjuvant therapy 
        
Yes 3 71% 8 20% 1 8% 12 18% 
No 39 29% 32 80% 12 92% 56 82% 
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Table 2: Pelvic venous pressure (PVP) in mmHg according to the randomization 
groups; data are presented with median values and ranges.* P<0.0001 for within-
group P value derived from the Wilcoxon signed rank test for within-patient or without 
and with abdominal lifting at the endpoint starting the PLND, end of the PLND and 
end of the cystectomy part, with Bonferroni adjustment. 
  
  
Norepinephrine / Control 
  
  
Overall 
 
Low-Volume Group Group 
 
    (n=183)   (n=82)   (n=81)   P-value 
Starting PLND 7 [0-16] 5 [0-13]* 8 [0-16]* < 0.0001 
with abdominal wall lifting 
  
2 [0-12] 3 [0-12] 0.007 
 
P-value within 
   
< 0.0001 
 
< 0.0001 
 
         
End of PLND 
 
6 [0-15] 4 [0-12]* 8 [0-15]* < 0.0001 
with abdominal wall lifting 
  
2 [-1-4] 3 [-2-9] < 0.0001 
 
P-value within 
   
< 0.0001 
 
< 0.0001 
 
        
End of cystectomy part 6 [-1-14] 4 [-1-12]* 7 [0-14]* < 0.0001 
with abdominal wall lifting 
  
1 [-2-6] 3 [0-8] < 0.0001 
 
P-value within 
   
< 0.0001 
 
< 0.0001 
 
        
After urinary diversion 5 [-1-13] 2 [-1-8] 6 [0-13] < 0.0001 
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Table 3: Blood loss, hemodynamic data and intraoperative blood unit transfusion rate 
according to the subgroups. Data are presented with median values and ranges or 
number and %. P-values: * P<0.0001 norepinephrine/low-volume group with PVP < 
5mmHg vs control group with PVP ≥ 5 mmHg; # P<0.05 norepinephrine/low-volume 
group with PVP < 5 mmHg vs control group with PVP < 5mmHg; ° P<0.0001 
norepinephrine/low-volume group with PVP ≥ 5 mmHg vs control group with PVP ≥ 5 
mmHg; ± P<0.0001 norepinephrine/low-volume group with PVP ≥ 5 mmHg vs control 
group with PVP < 5 mmHg. 
  
Norepinephrine/low-volume Group         Control Group 
    
(n=82) (n=81) 
PVP < 5mmHg PVP ≥ 5mmHg PVP < 5mmHg PVP ≥ 5mmHg 
n=42 n=40 n=13 n=68 
                  
P-value 
blood loss total  
(ml) 800 [300-1200]*# 900 [500-1800]° 1000 [600-160 0] 1300 [400-2800] <0.0001 
blood loss per min  
(ml/min) 1.8 [0.7-2.9]*# 2.0° [1.2-3.5]° 2.7 [1.5-3.7] 3.2 [2.9-3.5] 0.005  
blood loss PLND  
(ml) 100 [0-400] * 145 [0-300]° 150 [50-300] 200 [5 0-2000] <0.0001 
blood loss cystectomy 
(ml) 480 [200-850] *# 550 [300-1200]° 650 [500-1200 ] 900 [300-2300] <0.0001 
blood loss urinary 
diversion (ml) 100 [0-410] 200 [0-500] 150 [50-500] 200 [0-700] 0.049 
  
heart rate PLND 
(1.min-1) 66 [50-94] 66 [45-92] 60 [52-85] 65 [45-90] 0.167 
heart rate cystectomy 
(1.min-1) 70 [47-102] 67 [43-100] 65 [44-78] 63 [40-90] 0.123 
heart rate urinary 
diversion (1.min-1) 74 [50-107] 77 [41-100] 75 [55-90] 70 [40-98] 0.210 
MAP PLND  
(mmHg) 70 [60-85] 70 [60-93] 70 [60-84] 68 [60-90] 0.577 
MAP cystectomy 
(mmHg) 70 [60-85] 71 [60-93] 73 [60-81] 70 [60-100] 0.438 
MAP urinary diversion 
(mmHg) 72 [62-94] 72 [60-100] 70 [60-85] 70 [60-92] 0.684 
CVP baseline 
(mmHg) 12 [7-20] 13 [6-21] 14 [5-20] 13 [5-21] 0.132 
CVP PLND  
(mmHg) 12 [7-19] 13 [5-21] 15 [10-20] 15 [5-23] <0.0001 
CVP cystectomy 
(mmHg) 11 [4-23] 12 [2-23] 16 [10-20] 15 [2-25 <0.0001 
CVP urinary diversion 
(mmHg) 9 [3-22] 11 [4-19] 15 [9-20] 14 [3-29] <0.0001 
crystalloid  
(ml) 1500 [700-2500]*# 1800 [800-4000]°± 3800 [3000-6100] 4450 [2800-6200] <0.0 001 
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Figure 1: 
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Abbreviations and Acronyms: 
 
PLND = pelvic lymph node dissection 
RC = radical cystectomy 
UD = urinary diversion 
CVP = central venous pressure 
PVP = pelvic venous pressure 
MAP = mean arterial pressure 
RR = relative risk 
CI = confidence intervals 
OR = odds ratios 
ROC-AUC = receiver operating characteristic-area under the curve 
 
